Open AccessClinical Outcomes of CLL Patients with Relapsed or Refractory Disease after CD19-Specific CAR-T Therapy
Author(s) -
Mazyar Shadman,
Jordan Gauthier,
Sirin Khajavian,
Alexandre V. Hirayama,
Ryan C. Lynch,
Stephen D. Smith,
Chaitra S. Ujjani,
Victor A. Chow,
HansPeter Kiem,
Brian G. Till,
Ajay K. Gopal,
David G. Maloney,
Cameron J. Turtle
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.622
Subject(s) - medicine , adverse effect , refractory (planetary science) , car t cell therapy , gastroenterology , leukapheresis , progressive disease , surgery , oncology , cancer , disease , chimeric antigen receptor , immunotherapy , cd34 , physics , stem cell , astrobiology , biology , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom